Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

32.73
Delayed Data
As of Aug 28
 +1.04 / +3.28%
Today’s Change
27.92
Today|||52-Week Range
45.45
-19.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues106.0M117.9M99.9M113.7M
 
 
 
 
 
Cost of Goods Sold19.0M22.0M14.9M19.1M
 
 
 
 
 
Depreciation And Amortization1.8M3.1M3.7M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income85.2M92.7M81.2M90.8M
 
 
 
 
 
General Expenses62.2M77.8M79.4M84.0M
 
 
 
 
 
Research And Development16.6M25.9M30.6M31.2M
 
 
 
 
 
Total Operating Expenses82.9M103.0M98.0M106.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income23.1M14.9M1.8M6.8M
 
 
 
 
 
Extraordinary Credit--263.0K----
 
 
Extraordinary Charge-2.4M-14.0M-3.1M-1.1M
 
 
 
 
 
Interest Expense On Debt4.6M4.2M4.1M4.0M
 
 
 
 
 
Other Expenses167.0K0.00121.0K351.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income16.5M-2.7M-5.1M2.1M
 
 
 
 
 
Income Taxes-4.5M-3.0M-2.0M-1.1M
 
 
 
 
 
Net Income12.0M330.0K-3.1M997.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.1M41.5M42.0M42.1M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M43.1M42.0M43.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.28$0.01-$0.07$0.02
 
 
 
 
 
EPS Diluted$0.28$0.01-$0.07$0.02